Sign Out
ELIGARD is contraindicated in women and in paediatric patients.
Hypersensitivity to leuprorelin acetate, to other GnRH agonists or to any of the excipients listed in Description.
In patients who previously underwent orchiectomy (as with other GnRH agonists, ELIGARD does not result in further decrease of serum testosterone in case of surgical castration).
As sole treatment in prostate cancer patients with spinal cord compression or evidence of spinal metastases (see also Precautions).
